Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.
2.

Tumor suppressor p53 and its gain-of-function mutants in cancer.

Liu J, Zhang C, Feng Z.

Acta Biochim Biophys Sin (Shanghai). 2014 Mar;46(3):170-9. doi: 10.1093/abbs/gmt144. Epub 2013 Dec 29. Review.

3.

p53 mutations in cancer.

Muller PA, Vousden KH.

Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641. Review.

PMID:
23263379
4.

MicroRNAs, wild-type and mutant p53: more questions than answers.

Jones M, Lal A.

RNA Biol. 2012 Jun;9(6):781-91. doi: 10.4161/rna.20146. Epub 2012 Jun 1. Review.

5.

p53 as a Regulator of Lipid Metabolism in Cancer.

Parrales A, Iwakuma T.

Int J Mol Sci. 2016 Dec 10;17(12). pii: E2074. Review.

6.

Battle against cancer: an everlasting saga of p53.

Hao Q, Cho WC.

Int J Mol Sci. 2014 Dec 1;15(12):22109-27. doi: 10.3390/ijms151222109. Review.

7.

Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.

Stegh AH.

Expert Opin Ther Targets. 2012 Jan;16(1):67-83. doi: 10.1517/14728222.2011.643299. Epub 2012 Jan 12. Review.

8.

The Contrived Mutant p53 Oncogene - Beyond Loss of Functions.

Sabapathy K.

Front Oncol. 2015 Dec 10;5:276. doi: 10.3389/fonc.2015.00276. eCollection 2015. Review.

9.

(Nano)-materials and methods of signal enhancement for genosensing of p53 tumor suppressor protein: Novel research overview.

Hasanzadeh M, Shadjou N.

Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:1424-1439. doi: 10.1016/j.msec.2017.02.038. Epub 2017 Feb 20. Review.

PMID:
28482509

Supplemental Content

Support Center